Literature DB >> 11009331

Informativeness of structured diagnostic interviews in the identification of Tourette's disorder in referred youth.

B J Coffey1, J Biederman, T Spencer, D A Geller, S V Faraone, C A Bellordre.   

Abstract

Although specialized programs have greatly advanced the treatment of youth with Tourette's disorder (TD), not all children with TD reach such programs, raising questions as to whether TD is adequately identified outside specialized settings. There is thus a need for evidence that cases identified in the nonspecialty setting are "true cases." Because structured diagnostic interview methodology can reduce errors of omission, this approach can facilitate the identification of TD in referred youth outside specialized programs. Similarities between cases ascertained in specialty and nonspecialty settings would suggest that those identified in the nonspecialty setting were indeed "true cases." Comparisons were made between youth with TD ascertained through a specialized TD program who had both a structured diagnostic interview-derived diagnosis of TD plus an expert evaluation of TD (N = 103), with youth ascertained through a non-TD specialized pediatric psychopharmacology program who had a structured diagnostic interview-derived diagnosis of TD (N = 92). Irrespective of ascertainment source, children with structured interview-derived diagnosis of TD shared similar correlates in terms of tic severity, mean age of onset and duration of tics, as well as patterns of comorbidity well known to be associated with TD in clinical samples. Children meeting diagnostic criteria for TD on structured diagnostic interviews share similarities and patterns of clinical correlates, irrespective of ascertainment through a specialized TD or non-TD specialized clinic. These findings support the usefulness of structured diagnostic interview methodology as a diagnostic aid for the identification of TD in non-TD specialized settings and facilitate delineation of patterns of comorbidity.

Entities:  

Mesh:

Year:  2000        PMID: 11009331     DOI: 10.1097/00005053-200009000-00004

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  7 in total

1.  Pediatric autoimmune neuropsychiatric disorders associated with streptococcus: comparison of diagnosis and treatment in the community and at a specialty clinic.

Authors:  Vilma Gabbay; Barbara J Coffey; James S Babb; Laura Meyer; Carly Wachtel; Seeba Anam; Beth Rabinovitz
Journal:  Pediatrics       Date:  2008-08       Impact factor: 7.124

2.  Testing tic suppression: comparing the effects of dexmethylphenidate to no medication in children and adolescents with attention-deficit/hyperactivity disorder and Tourette's disorder.

Authors:  Gholson J Lyon; Stephanie M Samar; Christine Conelea; Marcel R Trujillo; Christina M Lipinski; Christopher C Bauer; Bryan C Brandt; Joshua J Kemp; Zoe E Lawrence; Jonathan Howard; F Xavier Castellanos; Douglas Woods; Barbara J Coffey
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-08       Impact factor: 2.576

3.  Utility of the diagnostic interview schedule for children for assessing Tourette syndrome in children.

Authors:  Adam B Lewin; Jonathan W Mink; Rebecca H Bitsko; Joseph R Holbrook; E Carla Parker-Athill; Camille Hanks; Eric A Storch; Erika F Augustine; Heather R Adams; Amy E Vierhile; Alyssa R Thatcher; Tanya K Murphy
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-05-09       Impact factor: 2.576

4.  Developmental psychopathology of children and adolescents with Tourette syndrome--impact of ADHD.

Authors:  Veit Roessner; Andreas Becker; Tobias Banaschewski; Roger D Freeman; Aribert Rothenberger
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-06       Impact factor: 4.785

5.  Children and adolescents with Tourette's disorder in the USA versus Argentina: behavioral differences may reflect cultural factors.

Authors:  Stephanie M Samar; María Beatriz Moyano; Marta Braña-Berríos; Gustavo Irazoqui; Angeles Matos; Rafael Kichic; Resham Gellatly; Laura Ibanez-Gomez; Amanda L Zwilling; Eva Petkova; Barbara J Coffey
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-04-09       Impact factor: 4.785

6.  Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study.

Authors:  Gholson J Lyon; Stephanie Samar; Rahil Jummani; Scott Hirsch; Arie Spirgel; Rachel Goldman; Barbara J Coffey
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-12       Impact factor: 2.576

7.  Paliperidone extended release for the treatment of pediatric and adolescent patients with Tourette's disorder.

Authors:  Kazuhiko Yamamuro; Manabu Makinodan; Toyosaku Ota; Junzo Iida; Toshifumi Kishimoto
Journal:  Ann Gen Psychiatry       Date:  2014-05-02       Impact factor: 3.455

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.